Vaccine

A vaccine is a biological preparation that improves immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism, and is often made from weakened or killed forms of the microbe. The agent stimulates the body's immune system to recognize the agent as foreign, destroy it, and "remember" it, so that the immune system can more easily recognize and destroy any of these microorganisms that it later encounters.

What are Vaccines?

There are several diseases like Diphtheria, whooping cough (pertussis), measles, mumps, Yellow fever, small pox and German measles (rubella) that are unfamiliar to many these days.

Vaccine History

What is a Vaccine Breakthrough?

What are the Main Causes of Vaccine Hesitancy?

Investigating the Importance of Investing in Vaccine Manufacturing

Vaccine Schedule

Vaccine Effectiveness

Vaccination in Humanitarian Settings

Plant-Derived Vaccines

Vaccine Production

Vaccine Excipients

Vaccine Delivery

See more featured articles »

Vaccine Immunity

Hib Immunization

History of Vaccination

How are Vaccines Stored?

What are the Different Types of Vaccines?

What is a Subunit Vaccine?

What is an Inactivated Vaccine?

What is a Live-Attenuated Vaccine?

What is a Toxoid Vaccine?

What is an RNA Vaccine?

What is a DNA Vaccine?

What are Adenovirus-Based Vaccines?

What is a Non-Replicating Vaccine?

What is a VLP Vaccine?

What are Nanoparticle-Based Vaccines?

The Future of Vaccines

Insight into Personalized Vaccines

Could there be a Salmonella Vaccine?

Role of Computer Modeling in Vaccine Development

How Veterinary Vaccines Affect Human Health

A New Breed of Vaccine: Exploring Doggybone ™ DNA Technology

What is the Importance of Vaccination Coverage?

The Big Catch-Up: How the COVID-19 pandemic impacted vaccination coverage

Latest Vaccine News and Research

Study reveals factors impacting pertussis antibody half-lives in infants, sheds light on preterm infants' resilience

Researchers compared two methods of half-life estimation to evaluate the half-life of maternal antibodies.

9 Jun 2023

Global trials could save lives by changing treatment procedure for cancer in the future

Researchers from Edith Cowan University (ECU) are leading ground-breaking global trials which could save lives by changing how we treat cancer in the near future.

9 Jun 2023

Trial finds mixed success of chatbots in improving COVID-19 vaccine confidence among Asians

Chatbots had mixed success in improving COVID-19 vaccine confidence and acceptance among the most hesitant individuals in Asia, according to a new randomized control trial.

8 Jun 2023

Yellow fever: examining potential burden on vaccine strategy

Researchers presented a stochastic model of yellow fever transmission.

8 Jun 2023

Do COVID-19 drugs in aquatic matrices negatively impact microalgae and cyanobacteria communities?

Researchers evaluated the presence of coronavirus disease 2019 (COVID-19) drugs in river water.

8 Jun 2023

University Hospital Centre for Emerging Viral Diseases named as a WHO collaborating center for epidemic and pandemic diseases

The World Health Organization (WHO), the University of Geneva (UNIGE) and Geneva University Hospitals (HUG), yesterday formalized the designation of the University Hospital Centre for Emerging Viral Diseases as a WHO collaborating center for epidemic and pandemic diseases.

8 Jun 2023

How the mixed messaging of vaccine skeptics sows seeds of doubt

It was a late-spring House of Representatives hearing, where members of Congress and attendees hoped to learn lessons from the pandemic. Witness Marty Makary made a plea.

8 Jun 2023

Safety surveillance suggests that COVID-19 mRNA vaccination is safe for young children

Researchers presented the results of their rapid cycle analysis safety surveillance, which is a weekly surveillance monitoring of monovalent mRNA COVID-19 vaccines among all children below five years enrolled in the Vaccine Safety Datalink (VSD).

8 Jun 2023

Study identifies a promising target for development of vaccine against spotted fever

A protein found in cells of the hard tick Amblyomma sculptum, the main vector of the bacterium that causes Brazilian spotted fever (also known as Rocky Mountain spotted fever), is essential to the tick's survival while feeding, making it a promising target for development of a vaccine, according to an article published in the journal Parasites & Vectors.

7 Jun 2023

The epidemiology of COVID-19 outbreaks in farms in Ontario, Canada, in the pre-vaccine year of the pandemic

Researchers discussed the farm outbreaks of COVID-19 in Ontario from January to December 2020.

7 Jun 2023

Global partnership to make UQ a major international hub for vaccine discovery and development

Queensland will become a major international hub for vaccine discovery and development with a global partnership formed in the United States today to help address the world's critical health challenges.

6 Jun 2023

Review finds no indications of serious side effects of COVID-19 vaccines given to young children

A review of more than 245,000 doses of mRNA COVID-19 vaccines given to young children (most of them age 4 and younger) found no indications of serious side effects.

6 Jun 2023

Breakthrough: Sequencing functional antibody proteins directly from human blood

Rapid Novor Inc., the world’s leader in mass spectrometry (MS)-based antibody protein sequencing, announced today that its REpAb® antibody discovery platform was used to successfully sequence a complex mixture of functional antibodies directly from the serum of a human patient after receiving a COVID-19 vaccine.

6 Jun 2023

Does COVID-19 vaccination affect the menstrual cycle?

The association of COVID-19 vaccination with menstrual cycle abnormalities.

6 Jun 2023

Cutting free flu jabs for 50-64-year-olds and mpox vaccines could lead to future strains on the NHS, says expert

...

5 Jun 2023

US blood donor study finds nearly half of population exhibits hybrid immunity to COVID-19

Hybrid immunity, resulting from both previous infection and vaccination, offers superior protection. Analysis of nationwide blood donor data reveals that by the third quarter of 2022, 96.4% of individuals had SARS-CoV-2 antibodies from previous infection or vaccination, with 47.7% having hybrid immunity.

4 Jun 2023

Lymphoid depletion associated with suppressed APC function characterizes the lethality of COVID-19 in mice

1
2
3
4
...
1049
Next

Vaccine

Overview

Feature Articles

Investigating the Importance of Investing in Vaccine Manufacturing

Vaccine Schedule

Vaccine Effectiveness

Vaccination in Humanitarian Settings

Plant-Derived Vaccines

Vaccine Production

Vaccine Excipients

Vaccine Delivery

Vaccine Immunity

Hib Immunization

History of Vaccination

How are Vaccines Stored?

What are the Different Types of Vaccines?

What is a Subunit Vaccine?

What is an Inactivated Vaccine?

What is a Live-Attenuated Vaccine?

What is a Toxoid Vaccine?

What is an RNA Vaccine?

What is a DNA Vaccine?

What are Adenovirus-Based Vaccines?

What is a Non-Replicating Vaccine?

What is a VLP Vaccine?

What are Nanoparticle-Based Vaccines?

The Future of Vaccines

Insight into Personalized Vaccines

Could there be a Salmonella Vaccine?

Role of Computer Modeling in Vaccine Development

How Veterinary Vaccines Affect Human Health

A New Breed of Vaccine: Exploring Doggybone ™ DNA Technology

What is the Importance of Vaccination Coverage?

The Big Catch-Up: How the COVID-19 pandemic impacted vaccination coverage

Latest Vaccine News and Research

Exploring the intersection of biology and proteomics

Unlocking the Secrets of Multiple Sclerosis Progression: Brain-Immune Cell Communication

Passing on Polycystic Ovary Syndrome: Health risks for male offspring of women with PCOS

Newsletters you may be interested in